Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v5-EN
Language English English
Date Updated 2022-04-12 2022-02-04
Drug Identification Number 01927698 01927698
Brand name NOZINAN INJ 25MG/ML NOZINAN INJ 25MG/ML
Common or Proper name Nozinan Nozinan
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients METHOTRIMEPRAZINE METHOTRIMEPRAZINE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 10
ATC code N05AA N05AA
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2022-01-12 2022-01-12
Estimated end date 2022-05-16 2022-04-14
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status Yes No
Company comments Lots received are not releasable at this time. Intermittent supply available. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Lots received are not releasable at this time. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments